...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of studies on alcohol and drugs. >Counselor attitudes toward pharmacotherapies for alcohol dependence.
【24h】

Counselor attitudes toward pharmacotherapies for alcohol dependence.

机译：辅导员对酒精依赖药物治疗的态度。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: Addiction treatment counselors play a central role in the dissemination of information about new treatment techniques to alcohol-dependent patients and are key in the implementation of new treatment technologies. Building on previous research, this study examines counselors' perceptions of the effectiveness and acceptability of pharmacotherapies for the treatment of alcohol dependence. METHOD: Mail questionnaires were received from 1,140 counselors employed in a nationally representative sample of public-sector addiction treatment programs in 2006. Counselors answered a series of questions about three U.S. Food and Drug Administration (FDA)-approved medications used in the treatment of alcohol dependence (disulfiram [Antabuse], tablet naltrexone [Revia], and acamprosate [Campral]), indicating their extent of familiarity with the medication, its perceived effectiveness in the treatment of alcohol dependence, and its acceptability for use with alcohol-dependent patients. RESULTS: The extent of diffusion of these pharmacotherapies was associated with time since FDA approval. Counselors reported receiving little or no pharmacotherapy-specific training. Multivariate models showed that the receipt of medication-specific training as well as indirect observation of the medication's use in the treatment program were significantly associated with diffusion of information about these pharmacotherapies and counselors' perceptions of the effectiveness and acceptability of the medications for use in addiction treatment. CONCLUSIONS: When exposed to information about medications to treat alcohol dependence, counseling staff appear quite receptive. More efforts are needed to disseminate information about alcohol pharmacotherapies to front-line addiction treatment staff.
机译：目的：成瘾治疗顾问在向酒精依赖患者传播有关新治疗技术的信息方面起着核心作用，并且是实施新治疗技术的关键。在以前的研究的基础上，本研究检查了辅导员对药物治疗酒精依赖治疗的有效性和可接受性的看法。方法：2006年，在全国代表性的公共部门成瘾治疗计划样本中，聘用了1,140名顾问的邮件调查问卷。顾问回答了有关美国食品药品管理局（FDA）批准的三种用于酒精治疗的药物的一系列问题依赖（双硫仑[Antabuse]，片剂纳曲酮[Revia]和阿坎酸（Campral）），表明他们对药物的熟悉程度，在酒精依赖治疗中的感知效力以及对酒精依赖患者的接受程度。结果：自FDA批准以来，这些药物疗法的扩散程度与时间有关。辅导员报告说很少或没有接受药物治疗方面的专门培训。多变量模型表明，接受针对药物的培训以及对治疗方案中药物使用情况的间接观察与这些药物治疗信息的传播以及咨询师对成瘾药物的有效性和可接受性的看法密切相关。治疗。结论：当接触到有关治疗酒精依赖药物的信息时，咨询人员显得很容易接受。需要作出更大的努力向一线成瘾治疗人员传播有关酒精药物治疗的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号